데이터셋 상세
캘리포니아 오픈데이터
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) in California Hospitals
California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) identified in their facilities to the California Department of Public Health (CDPH). MRSA BSI data are submitted by hospitals to the Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN). CDPH downloads California hospital MRSA BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual MRSA BSI data reported by each California hospital in the datasets below. The following datasets include the number of MRSA BSI reported by each California hospital in the specified reporting year. Beginning in 2016 for each California hospital, the annual MRSA BSI dataset includes the number of MRSA BSI that were predicted to occur in each hospital based on its specific facility-level characteristics. The observed (reported) number of MRSA BSI are then compared to the predicted number of MRSA BSI in a ratio called the Standardized Infection Ratio or SIR. The SIR is a metric that summarizes an individual hospital’s MRSA BSI prevention progress compared with the national baseline and California state-specific prevention goals. The datasets also include the associated 95% confidence intervals for the SIR and statistical interpretation to show whether MRSA BSI incidence was the same (no different), better (lower) or worse (higher) than the national baseline. Another performance measure in this dataset allows for tracking hospital progress in meeting national HAI reduction goals. Hospitals must have an SIR at or below incremental targets each year to be considered on track. Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest. For more information about the SIR and NHSN’s statistical models that are used to calculate the predicted number of MRSA BSI for each hospital, please review “NHSN’s Guide to the SIR”: https://www.cdc.gov/nhsn/ps-analysis-resources/index.html For general information about NHSN, surveillance definitions, and reporting requirements for MRSA BSI, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including HCAI, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx
연관 데이터
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) in California Hospitals
공공데이터포털
California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) identified in their facilities to the California Department of Public Health (CDPH). MRSA BSI data are submitted by hospitals to the Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN). CDPH downloads California hospital MRSA BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual MRSA BSI data reported by each California hospital in the datasets below. The following datasets include the number of MRSA BSI reported by each California hospital in the specified reporting year. Beginning in 2016 for each California hospital, the annual MRSA BSI dataset includes the number of MRSA BSI that were predicted to occur in each hospital based on its specific facility-level characteristics. The observed (reported) number of MRSA BSI are then compared to the predicted number of MRSA BSI in a ratio called the Standardized Infection Ratio or SIR. The SIR is a metric that summarizes an individual hospital’s MRSA BSI prevention progress compared with the national baseline and California state-specific prevention goals. The datasets also include the associated 95% confidence intervals for the SIR and statistical interpretation to show whether MRSA BSI incidence was the same (no different), better (lower) or worse (higher) than the national baseline. Another performance measure in this dataset allows for tracking hospital progress in meeting national HAI reduction goals. Hospitals must have an SIR at or below incremental targets each year to be considered on track. Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest. For more information about the SIR and NHSN’s statistical models that are used to calculate the predicted number of MRSA BSI for each hospital, please review “NHSN’s Guide to the SIR”: https://www.cdc.gov/nhsn/ps-analysis-resources/index.html For general information about NHSN, surveillance definitions, and reporting requirements for MRSA BSI, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including OSHPD, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/HAIreport.aspx
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) in California Hospitals
공공데이터포털
California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) identified in their facilities to the California Department of Public Health (CDPH). MRSA BSI data are submitted by hospitals to the Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN). CDPH downloads California hospital MRSA BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual MRSA BSI data reported by each California hospital in the datasets below. The following datasets include the number of MRSA BSI reported by each California hospital in the specified reporting year. Beginning in 2016 for each California hospital, the annual MRSA BSI dataset includes the number of MRSA BSI that were predicted to occur in each hospital based on its specific facility-level characteristics. The observed (reported) number of MRSA BSI are then compared to the predicted number of MRSA BSI in a ratio called the Standardized Infection Ratio or SIR. The SIR is a metric that summarizes an individual hospital’s MRSA BSI prevention progress compared with the national baseline and California state-specific prevention goals. The datasets also include the associated 95% confidence intervals for the SIR and statistical interpretation to show whether MRSA BSI incidence was the same (no different), better (lower) or worse (higher) than the national baseline. Another performance measure in this dataset allows for tracking hospital progress in meeting national HAI reduction goals. Hospitals must have an SIR at or below incremental targets each year to be considered on track. Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest. For more information about the SIR and NHSN’s statistical models that are used to calculate the predicted number of MRSA BSI for each hospital, please review “NHSN’s Guide to the SIR”: https://www.cdc.gov/nhsn/ps-analysis-resources/index.html For general information about NHSN, surveillance definitions, and reporting requirements for MRSA BSI, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including HCAI, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx
2016 Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection (BSI) Laboratory-Identified (LabID) Events Table – Acute Care Hospitals (Updated Baseline)
공공데이터포털
Oregon hospitals report facility-wide MRSA BSIs as part of Oregon’s mandatory healthcare-associated infections reporting program. For information regarding standardized infection ratio baselines, please see https://www.cdc.gov/nhsn/2015rebaseline/index.html
2016 Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection (BSI) Laboratory-Identified (LabID) Events Table – Critical Access Hospitals (Updated Baseline)
공공데이터포털
Oregon hospitals report facility-wide MRSA BSIs as part of Oregon’s mandatory healthcare-associated infections reporting program. For information regarding standardized infection ratio baselines, please see https://www.cdc.gov/nhsn/2015rebaseline/index.html
2017 Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection (BSI) Laboratory-Identified (LabID) Events Table – Critical Access Hospitals
공공데이터포털
Oregon hospitals report facility-wide MRSA BSIs as part of Oregon’s mandatory healthcare-associated infections reporting program. For information regarding standardized infection ratio baselines, please see https://www.cdc.gov/nhsn/2015rebaseline/index.html
Vancomycin-Resistant Enterococci (VRE) Bloodstream Infections in California Hospitals
공공데이터포털
California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of vancomycin-resistant enterococci (VRE) bloodstream infections (BSI) to the California Department of Public Health (CDPH). Hospitals report VRE data to CDPH via the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) following NHSN protocols and definitions. CDPH downloads California hospital VRE BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual VRE BSI data in datasets that include the number of VRE BSI reported by each California hospital in the specified reporting year and the hospital-onset VRE BSI rate. The VRE BSI rate is calculated by dividing the number of cases by the total number of patient days; the rate is then reported per 10,000 patient days. VRE BSI rates are not risk adjusted because there are no such methods available at this time. Aggregate mean rates used for comparisons are stratified by hospital type (and for community hospitals, by bed size). The unadjusted VRE BSI rates herein are affected by the clinical services provided, infection control practices, and surveillance methods. Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest. For general information about NHSN, surveillance definitions, and reporting requirements for VRE, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including HCAI, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx
Vancomycin-Resistant Enterococci (VRE) Bloodstream Infections in California Hospitals
공공데이터포털
California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of vancomycin-resistant enterococci (VRE) bloodstream infections (BSI) to the California Department of Public Health (CDPH). Hospitals report VRE data to CDPH via the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) following NHSN protocols and definitions. CDPH downloads California hospital VRE BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual VRE BSI data in datasets that include the number of VRE BSI reported by each California hospital in the specified reporting year and the hospital-onset VRE BSI rate. The VRE BSI rate is calculated by dividing the number of cases by the total number of patient days; the rate is then reported per 10,000 patient days. VRE BSI rates are not risk adjusted because there are no such methods available at this time. Aggregate mean rates used for comparisons are stratified by hospital type (and for community hospitals, by bed size). The unadjusted VRE BSI rates herein are affected by the clinical services provided, infection control practices, and surveillance methods. Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest. For general information about NHSN, surveillance definitions, and reporting requirements for VRE, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including HCAI, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx